GlassScriptPhysician profile
Rodney B Dade
NPI 1336117373
$3,975.81
in general payments reported to CMS, 2019-2025
41 companies · $626 in 2025
The $626 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $583 · 2021: $497 · 2022: $513 · 2023: $256 · 2024: $616 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $541.02 | 2022-2025 | Ubrelvy, Botox |
| Allergan, INC. | $293.85 | 2019-2021 | |
| Ibsa Pharma INC. | $256.91 | 2020-2025 | Tirosint, Licart, Tirosint |
| Abbott Laboratories | $237.32 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $236.80 | 2019-2024 | Euflexxa |
| Depuy Synthes Sales INC. | $226.85 | 2019-2025 | Monovisc, Orthovisc, Peak |
| Collegium Pharmaceutical, INC. | $189.54 | 2019-2025 | Belbuca, Xtampza |
| Grt US Holding, INC. | $177.81 | 2021-2022 | |
| Vertos Medical, INC. | $141.96 | 2024 | Mild Device Kit |
| Arbor Pharmaceuticals, INC. | $135.92 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $129.23 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $123.68 | 2019-2022 | |
| Medtronic USA, INC. | $98.83 | 2019 | |
| Merz North America, INC. | $95.44 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.67 | 2022-2024 | Relistor |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Dade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.